source
- Biopharma launches nominations for 2025 pay report and highlights Parabilis record IPOEndpoints Weekly announced the start of nominations for its eighth annual Women in Biopharma report, aiming to feature 20 distinguished women across science, leadership, and entrepreneurship. The…
- Merck's Welireg and Keytruda combo receives FDA approval for adjuvant kidney cancer therapyMerck announced that its combination of the oral VEGFR inhibitor Welireg and the immunotherapy Keytruda has been cleared by the U.S. Food and Drug Administration. The clearance applies to patients…